Fig. 7From: Impact of Docetaxel on blood-brain barrier function and formation of breast cancer brain metastasesIF analyses of junctional BBB signature-proteins in MBMEC-monolayer. Representative IF-stainings of signature BBB-proteins. a 24 h treatment; b, c 24 h and 72 h treatment as depicted, (a, b) scale bar, 20 μm; karyorrhexis, <; c scale bar, 50 μmBack to article page